Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 11

Results For "NIV"

1165 News Found

Virohan launches Rs. 2 crore scholarship to promote health education among women
Healthcare | June 03, 2026

Virohan launches Rs. 2 crore scholarship to promote health education among women

The initiative opens pathways for female students to pursue healthcare programs across 20+ top universities and colleges in India


Abbott highlights prognostic value of MRD testing for breast cancer recurrence
Clinical Trials | June 03, 2026

Abbott highlights prognostic value of MRD testing for breast cancer recurrence

New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients


Cancer drug “iza-bren” posts strong Phase 3 wins across multiple tumor types
Clinical Trials | June 03, 2026

Cancer drug “iza-bren” posts strong Phase 3 wins across multiple tumor types

The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials


Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6
News | June 03, 2026

Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6

First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept


Scientists develop rapid nanosensor to detect gut health biomarker for IBD and diabetes
R&D | June 02, 2026

Scientists develop rapid nanosensor to detect gut health biomarker for IBD and diabetes

Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices


BioNTech and Bristol Myers Squibb drug shows strong early signal in lung cancer trial
Clinical Trials | June 02, 2026

BioNTech and Bristol Myers Squibb drug shows strong early signal in lung cancer trial

The safety profile was described as manageable, though not without notable toxicities


Bristol Myers Squibb wins EU approval for Opdivo-based frontline treatment in advanced hodgkin lymphoma
Drug Approval | June 02, 2026

Bristol Myers Squibb wins EU approval for Opdivo-based frontline treatment in advanced hodgkin lymphoma

The approval is supported by results from the Phase 3 SWOG 1826 trial


Dr. Morepen partners with VIT Bhopal to launch integrated on-campus health centre
Healthcare | June 01, 2026

Dr. Morepen partners with VIT Bhopal to launch integrated on-campus health centre

The company plans to establish similar healthcare centres across universities, schools, and corporate campuses nationwide


National Policy Dialogue adopts landmark 10-point declaration for people with disabilities
Healthcare | June 01, 2026

National Policy Dialogue adopts landmark 10-point declaration for people with disabilities

World MS Day 2026 conclave brings together MPs, neurologists, disability rights advocates and insurance stakeholders to push for reforms in healthcare access, disability recognition and social protection